Health ❯Healthcare ❯Pharmaceuticals ❯Drug Safety

Mifepristone

FDA Commissioner Pledges Safety Review of Abortion Pill Mifepristone

The review responds to a conservative think tank’s report on serious side effects following mifepristone use.

HHS Orders FDA Review of Abortion Pill Following Controversial Analysis

Abortion Pill Study Fuels Debate Over Safety and Access

New Study Reveals Abortion Pill Complication Rate 22 Times Higher Than FDA Estimate

Marty Makary Faces Scrutiny in Confirmation Hearing for FDA Leadership

RFK Jr.’s HHS Nomination Faces Bipartisan Scrutiny Over Vaccine Stance and Conflicts of Interest